Loading...

Life Sciences Challenges Will Limit Prospects But Synergies Will Aid

Published
09 Aug 25
n/a
n/a
AnalystLowTarget's Fair Value
n/a
Loading
1Y
-33.5%
7D
2.5%

Author's Valuation

US$553.4% overvalued intrinsic discount

AnalystLowTarget Fair Value